Advancing Discovery Through Translational Preclinical CRO Services
We leverage a validated portfolio of preclinical assays and in vivo disease models, backed by decades of immunology expertise, to support preclinical-stage drug discovery across immune-mediated, inflammatory and infectious disease.
TICRO scientists partner with clients to de-risk the biology. Our scientific team designs custom preclinical studies that address complex disease questions, reduce scientific uncertainty and position you to receive high-quality data to better inform decision making before advancing to the clinic.
In Vivo Models
In vivo animal models facilitate evaluation of the effectiveness of new drugs, vaccines and/or therapeutic regimens as well as their effect on immune cell responses. Our small animal platform is well suited for efficacy testing, proof-of-concept studies and mechanism-of-action work.
Diagnostic Assays
TICRO boasts qualified, highly trained personnel combined with access to state-of-the-art facilities, including Immunohistochemistry, Flow Cytometry, Microscopy and Imaging and Molecular Biology Core Facilities, to meticulously conduct experiments and in vitro/ex vivo assays according to study specifications.
Custom Study Design
TICRO scientists build each study around your compound. They choose the model, dose, route, timepoints and readouts based on the question you're trying to answer, then refine the protocol with you before any work begins. Programs at different stages need different evidence, and each study is scoped accordingly.